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B cells develop in a multistep process from   
hematopoietic stem cells (HSCs) and lymphoid-
primed multipotent progenitors (LMPPs) into 
committed B cells that express a B cell receptor 
(BCR;  Kee  and  Paige,  1995;  Hardy  et  al., 
2007). B cell development has been well char-
acterized mainly based on the developmental 
stage-specific  rearrangement  of  the  Ig  heavy 
chain (IgH) and light chain loci (Alt et al., 1984; 
Cedar and Bergman, 1999). In pro–B cells, IgH 
DJ rearrangement precedes that of VDJ join-
ing. Upon expression of a productive VDJ 
gene rearrangement, a pre-BCR is formed that 
acts, in turn, to suppress the expression of the 
RAG1 and RAG2 proteins, and to promote 
the  survival  and  proliferation  of  developing 
large pre–B cells. The proliferation phase is fol-
lowed by cell-cycle arrest, during which RAG 
gene expression is reinduced to permit Ig light 
chain gene rearrangement. In the presence of 
self-reactivity, continued Ig light chain DNA 
recombination  will  replace  primary  Ig  VJ 
joints, ultimately generating BCRs with novel 
and innocuous specificities (Radic et al., 1993; 
Tiegs et al., 1993). Once a BCR has formed 
that lacks self-reactivity, tonic signaling medi-
ated  by  the  BCR  will  permanently  inhibit 
RAG1 and RAG2 gene expression and pro-
mote positive selection. Positively selected B 
cells migrate to the peripheral lymphoid organs 
where they, upon interacting with pathogenic 
determinant, will undergo class switch recom-
bination and somatic hypermutation, and dif-
ferentiate into plasma or memory B cells (Gellert, 
2002; Nemazee, 2006).
The specification and commitment of he-
matopoietic progenitors to the B cell lineage 
and their maturation into mature B-lineage 
cells requires the activities of multiple transcrip-
tion factors, including E2A, early B cell factor 
(EBF), and Pax5 (Nutt and Kee, 2007). The 
E2A proteins E12 and E47, which arise through 
alternative splicing of the Tcfe2a gene, belong to 
a subset of helix-loop-helix (HLH) proteins 
named E proteins. E proteins are transcriptional 
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The E2A gene products, E12 and E47, are critical regulators of B cell development. How-
ever, it remains elusive whether E12 and E47 have overlapping and/or distinct functions 
during B lymphopoiesis. We have generated mice deficient for either E12 or E47 and 
examined their roles in B cell maturation. We show that E47 is essential for developmental 
progression at the prepro–B cell stage, whereas E12 is dispensable for early B cell develop-
ment, commitment, and maintenance. In contrast, both E12 and E47 play critical roles in 
pre–B and immature B cells to promote immunoglobulin  (Ig) germline transcription as 
well as Ig VJ gene rearrangement. Furthermore, we show that E12 as well as E47 is re-
quired to promote receptor editing upon exposure to self-antigen. We demonstrate that 
increasing levels of E12 and E47 act to induce Ig germline transcription, promote tri-
methylated lysine 4 on histone 3 (H3) as well as H3 acetylation across the J region, and 
activate Ig VJ gene rearrangement. We propose that in the pre–B and immature B cell 
compartments, gradients of E12 and E47 activities are established to mechanistically 
regulate the sequential rearrangement of the Ig light chain genes.
© 2009 Beck et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e2272 DISTINCT FUNCTIONS FOR E12 AND E47 IN B CELL DEVELOPMENT | Beck et al.
genes contain binding sites for E2A, EBF, and Pax5 in puta-
tive promoter and enhancer regions, raising the possibility 
that the combined activities of E2A, EBF, and Pax5 initiate 
the B cell fate (Nutt and Kee, 2007).
Upon expression of a pre-BCR, E47 protein levels tran-
siently decline, whereas Id3 levels are elevated (Schebesta   
et al., 2002; Quong et al., 2004). E12 protein levels have 
not been studied in detail. At the small pre–B cell stage, E47 
levels increase again to induce Ig VJ gene rearrangement 
(Quong et al., 2004). E47 expression remains high at the 
immature B cell stage when interaction of the BCR with 
self-antigen promotes receptor editing (Quong et al., 2004). 
During positive selection within the transitional B cell com-
partments, E47 levels decrease and then decline further at 
the IgM+IgD+ stage (Quong et al., 2004; Kwon et al., 2008). 
We have previously proposed a model in which high abun-
dance of E47 enforces the immature B cell checkpoint 
(Quong et al., 2004). In the presence of self-reactivity, E47 
levels remain high to promote continuous Ig locus accessi-
bility and receptor editing. The expression of an innocuous 
BCR would lead to a decline of E47 levels, suppressing fur-
ther Ig light chain recombination and promoting develop-
mental progression toward the mature B cell stage. The 
E2A proteins initiate Ig VJ gene rearrangement by directly 
binding to the E-box sites located within the Ig intronic 
(iE) and 3 enhancers (Murre et al., 1989). Mutational 
analysis of the two E2A binding sites in iE affects Ig rear-
rangement as severely as deletion of the entire enhancer, 
providing unambiguous evidence for a critical function of 
E-box  sites  in  Ig  enhancer  function  (Greenbaum  and 
Zhuang, 2002a; Inlay et al., 2004). Enforced expression of 
E47 or E12 readily promotes Ig locus accessibility to the 
recombination machinery in nonlymphoid cells, and E2A-
deficient pre–B cells are defective in their ability to undergo 
Ig VJ gene rearrangement (Romanow et al., 2000; Goebel 
et al., 2001; Lazorchak et al., 2006a). Finally, secondary re-
arrangements and receptor editing are severely impaired in 
E2A-heterozygous mice (Quong et al., 2004).
Because the E2A proteins fulfill fundamental roles in so 
many aspects of the lymphoid branch of the hematopoietic 
system, it is important to determine in detail how they exert 
their unique effects. In particular, although the role of E2A 
proteins in lymphocyte development is now well established, 
it is less clear whether E12 and E47 have overlapping and re-
dundant roles or whether they perform distinct functions. Pre-
vious studies have described the phenotypes in mice that lack 
E47 expression (Bain et al., 1997). B cell development in E47-
ablated mice was blocked at a similar stage as in E2A-deficient 
mice, although low levels of Ebf1 and Pax5 transcripts were 
detectable (Bain et al., 1997). However, because of the applied 
gene  targeting  strategy,  these  mice  showed  a  substantially 
lower abundance of E12, and it remained unclear whether the 
defects that were detected were caused by a decrease in E12 
and E47 rather than E47 alone (Bain et al., 1997).
To determine the individual roles of E12 and E47 in B 
cell development, we have generated E12- and E47-deficient 
regulators that contain an HLH dimerization domain, as well 
as a basic DNA binding region that is located immediately N 
terminal to the HLH domain. E proteins form homodimers 
or heterodimers with other E proteins or other members of 
the HLH family (Murre, 2005). These protein complexes 
have the ability to act either as transcriptional activators or re-
pressors. In vertebrates, four E proteins have been identified. 
These include the E2A proteins, E12 and E47, which only 
differ in their basic DNA binding region, as well as HEB and 
E2-2, both of which give rise to distinct isoforms generated 
through alternative initiation of transcription (Corneliussen 
et al., 1991; Wang et al., 2006). E proteins also have the 
capacity to interact with antagonistic HLH proteins, named 
Id proteins. Id proteins contain an HLH domain but lack 
a basic region, and upon interacting with E proteins, inacti-
vate their DNA binding activity (Benezra et al., 1990). E and 
Id proteins are widely expressed throughout the entire hema-
topoietic system. They play critical roles at virtually every 
step of hematopoiesis to promote developmental progres-
sion, expansion, and survival of developing lymphocytes 
(Lazorchak et al., 2005; Murre, 2005).
The E2A proteins are active at the HSC cell stage, where 
they are required for the maintenance of the stem cell pool 
(Yang et al., 2008; Semerad et al., 2009). They remain active 
during  the  development  of  HSCs  into  LMPPs,  common 
lymphoid progenitors (CLPs), and prepro–B cells (Zhuang 
et al., 2004; Borghesi et al., 2005; Dias et al., 2008; Yang 
et al., 2008; Semerad et al., 2009). In the absence of E2A, the 
LMPP and CLP compartments are severely reduced and the 
pro–B cell compartment is completely absent (Dias et al., 
2008; Semerad et al., 2009). In both the LMPP and CLP 
compartment, the E2A proteins have been postulated to act 
in concert with other transcriptional regulators, such as PU.1 
and Ikaros, to promote further developmental progression 
(Singh et al., 2007; Nutt and Kee, 2007).
B cell development in E2A-ablated mice is arrested at the 
prepro–B cell stage before the onset of IgH DJ gene rear-
rangement (Bain et al., 1994; Zhuang et al., 1994). A similar 
block in B cell development is also observed in EBF-defi-
cient mice, and recent data have demonstrated that the E2A 
proteins act upstream of EBF to promote B-lineage matura-
tion (Lin and Grosschedl, 1995; Ikawa et al., 2004; Roessler 
et al., 2007). Specifically, forced EBF expression in E2A-
  deficient bone marrow cells relieves the block at the prepro–B 
cell stage (Seet et al., 2004). These data suggest that in the 
absence of E2A, B lymphopoiesis is blocked before the initia-
tion of B cell development, owing to the inability to activate 
Ebf1 transcription in prepro–B cells. The E2A proteins are 
also required to promote a B-lineage program of gene ex-
pression in pro–B cells, because conditional deletion of Tcfe2a 
revealed that the E2A proteins act to maintain the expression 
of Ebf1 and Pax5 in pro–B cells. The block at the prepro–B 
cell stage in E2A-deficient bone marrow is also relieved by 
the enforced expression of Pax5, likely because of the ability 
of Pax5 to regulate Ebf1 expression (Lazorchak et al., 2006b; 
Kwon et al., 2008). In addition, multiple pro–B cell–specific JEM VOL. 206, September 28, 2009 
ARTICLE
2273
To determine whether the excision of the E47 exon af-
fects E12 mRNA abundance, LMPPs and CLPs were iso-
lated from wild-type and E47/ bone marrow, and mRNA 
was  isolated  and  examined  for  the  expression  of  E12  by 
quantitative PCR (Fig. S2). Preliminary data show that in 
both the LMPP and CLP compartment, E12 levels in the 
E47-deficient cells were similar to that of their wild-type 
counterparts (Fig. S2). These data indicate that the block in 
early B cell development in E47/ mice is specifically caused 
by the depletion of E47 expression. Collectively, these data 
show that E12 does not play a critical role in early B-lineage 
specification. In contrast, E47 is indispensable at the earliest 
stages of B cell commitment.
E12 is required to promote the development  
of B cells expressing Ig
As described in the previous section, B cell development in 
E12/ mice seems to be slightly blocked at the transition 
from Hardy fraction C to the small pre–B cell stage, raising 
the possibility that E12 is required during the small pre–B 
cell stage. To examine this possibility, bone marrow derived 
from E12/ mice was analyzed for the abundance of pro–B 
cells (B220+IgMc-kit+), pre–B cells (B220+IgMCD25+), 
immature B cells (B220intermediateIgM+), and recirculating 
B cells (B220hiIgM+) using flow cytometry (Fig. 3 A). As 
predicted, the size of the pre–B cell compartment was slightly 
reduced in E12/ bone marrow (Fig. 3 A). On the other 
hand, the pro–B, immature B, and mature B cell compart-
ments were not altered in E12/ bone marrow as compared 
with wild-type controls (Fig. 3 A). Similarly, the cellularity 
of immature B cells (B220+IgM+IgDlo), transitional B cells 
(B220+IgM+IgD+), mature B cells (B220+IgMloIgD+), follic-
ular B cells (B220+CD23+CD21+), and marginal zone B cells 
(B220+CD23CD21hi) in the spleen was similar in E12/ as 
compared with wild-type mice (Fig. 3 B).
Previous studies demonstrated a critical role for the E2A 
proteins in receptor editing (Quong et al., 2004). Further-
more, a substantial reduction in the fraction of Ig-express-
ing cells was observed in E2A+/ mice. To determine whether 
E12 plays a critical role in the development and/or survival 
of Ig-expressing cells, E12/ bone marrow was analyzed 
for the presence of Ig1-3
+ cells by flow cytometry. Strik-
ingly, the fraction of Ig-expressing B cells was substantially 
reduced in E12/ mice as compared with those of wild-type 
littermates (Fig. 3, C and D). Similarly, total numbers of Ig+ 
cells in the bone marrow of E12/ mice were significantly 
reduced as compared with those of wild-type mice (Fig. 3 D). 
Comparable reductions were observed among newly formed 
B220intermediate and recirculating B220hi bone marrow B cells 
as well as in splenic B cells (Fig. 3, C and D). In contrast, the 
fraction of Ig-expressing cells was slightly elevated in the 
bone marrow as well as in the spleen of E12/ mice, result-
ing in a much higher Ig/Ig ratio in E12/ mice (Fig. 3 E). 
In summary, these data show that E12 plays a distinct and es-
sential role in the developmental progression and/or survival 
of B cells that express Ig.
mice and analyzed them for abnormalities during B lym-
phopoiesis. We found that deletion of E47 leads to a block 
in early B cell development, whereas E12 is dispensable for 
B cell specification. During later stages of development, 
however, there is a critical dependence on E12 as well as 
E47 expression in the pre–B and immature B cell compart-
ment.  Specifically,  using  both  in  vitro  and  in  vivo  ap-
proaches, we show that E12 and E47 play a crucial role in 
promoting Ig VJ gene rearrangement and receptor editing. 
Specifically, we demonstrate that the E2A proteins modu-
late trimethylated lysine 4 on histone 3 (H3K4me3) across 
the Ig J regions. These data link E2A, epigenetic marking, 
and the recruitment of the RAG proteins in a common 
pathway. Finally, we propose a model in which a gradient 
of E12 and E47 acts to sequentially regulate Igk and Ig VJ 
gene rearrangement.
RESULTS
Essential role for E47 but not E12 in early B cell development
To examine the individual roles of E12 and E47 in B cell de-
velopment, mice were generated that were either deficient in 
E12 or E47 (Fig. 1 A). To generate E12/ and E47/ mice, 
exons encoding for either E12 or E47 were flanked with loxP 
sites by homologous recombination in embryonic stem (ES) 
cells (Fig. 1 A). Genomic DNA was isolated from targeted ES 
cells and analyzed by Southern blotting for correct targeting 
(Fig. 1 B). Mutant mice were generated from cells carrying 
the floxed E12 or E47 alleles and crossed with transgenic 
mice that express the Ella-cre transgene to delete the loxP-
flanked DNA regions in the germline (Lakso et al., 1996). 
Mice carrying specific deletions in either E12 or E47 were 
identified using PCR on genomic DNA (Fig. 1 C).
To determine whether E12 and/or E47 is required to 
promote early B cell development, bone marrow derived 
from E12/ and E47/ mice was examined for cellularity 
as well as for the presence of B cell markers. In bone marrow 
and spleen derived from E47/ mice, B cells were virtually 
absent (Fig. 2, A and B). In contrast, the number of B cells in 
E12/ mice was not significantly altered as compared with 
wild-type mice (Fig. 2, A and B).
Previous studies using E2A/ mice have revealed that 
B cell development in these mice is blocked at the prepro–B 
cell stage, because the majority of the cells are arrested in 
Hardy fraction A (Bain et al., 1997). To more precisely deter-
mine the arrest in B cell development in E47/ mice, bone 
marrow was isolated and analyzed by flow cytometry for the 
expression of B220, CD43, heat stable antigen (HSA), and 
BP-1 (Fig. 2 C; Hardy and Hayakawa, 2001). B cell develop-
ment in E47/ mice was partially blocked in fraction A and 
a substantial fraction of cells could be detected in fraction B, 
whereas virtually no B cells could be detected in fraction C 
(Fig. 2, C and D). As expected, the B220+c-kit+ compartment   
was also severely reduced in E47/ bone marrow (Fig. S1). 
Interestingly, E12/ mice showed a slightly higher percent-
age of fraction C cells among the B220+CD43+ population than 
wild-type controls (Fig. 2, C and D).2274 DISTINCT FUNCTIONS FOR E12 AND E47 IN B CELL DEVELOPMENT | Beck et al.
compared with nontransgenic control recipients (Fig. S3 B). 
This increase in Ig-expressing cells was similar or even greater 
in the absence as compared with the presence of E12. How-
ever, the fraction of Ig-expressing cells in -macroself recipi-
ents reconstituted with E12/ cells was significantly lower as 
compared with those reconstituted with bone marrow cells 
from wild-type littermate controls (Fig. S3, A and B).
As expected, tolerance was maintained because no Ig-
expressing cells were detectable in the spleen of recipients 
expressing the -macroself antigen transplanted with either 
wild-type or E12/ bone marrow (Fig. S3 C, bottom). The 
fraction of Ig-expressing cells in the spleens of recipients 
that express the -macroself transgene was significantly lower 
in E12/ bone marrow as compared with wild-type chime-
ras (Fig. S3, C and D, top). Furthermore, the overall decrease 
in the total number of splenic B cells was much more sub-
stantial  in  E12/  chimeras  as  compared  with  controls   
(Fig. S3 D, bottom). Collectively, these data indicate that 
Defective receptor editing in E12/ mice
The aforementioned data show that the Ig/Ig ratio was se-
verely perturbed in E12/ B cells, raising the possibility that 
E12 plays a critical role in promoting Ig VJ gene rearrange-
ment upon exposure to self-antigen. To determine whether 
E12 plays a role in promoting receptor editing, bone marrow 
cells were isolated from wild-type and E12/ mice and trans-
planted into recipients that constitutively express a -macroself 
transgene (Ait-Azzouzene et al., 2005). 6 wk after transplanta-
tion, bone marrow as well as spleen cells were harvested and 
examined for the expression of Ig, Ig, and B220 (Fig. S3). 
As shown previously, the bone marrow of recipients express-
ing the -macroself transgene that received wild-type cells 
showed an increased frequency of Ig+ B cells as compared 
with recipients that lacked -macroself expression (Fig. S3 B). 
Similarly our preliminary results show that mice that received 
E12/ bone marrow cells also have increased percentages of 
Ig+ cells if recipients expressed the -macroself transgene as 
Figure 1.  Generation of E12- and E47-deficient mice. (A) Structure of the targeted Tcfe2a locus. The alternatively spliced E12 and E47 exons, re-
spectively, were flanked with loxP sites (indicated by arrows). In addition, a tetracysteine tag (black bar) was inserted into exon 20, 3 of the coding region, 
to produce tagged E47 and E12 proteins. Furthermore, a neomycin (neo) resistance gene was introduced to screen for targeted ES cells. The EcoRI (E) 
fragments as well as the probe used for screening of the ES cells are indicated. After crossing of Tcfe2afl_E12- or Tcfe2afl_E47-bearing mice with a germline 
Cre-deleter strain (Ella-Cre), the corresponding Tcfe2aE12 or Tcfe2aE47 strains were obtained. (B) Southern blot analysis of EcoRI-digested DNA from 
correctly targeted ES cells of the indicated genotype. The position of the probe is shown in A. (C) PCR analysis of genomic DNA from mice of the indicated 
genotype. Primer positions are depicted in A.JEM VOL. 206, September 28, 2009 
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progression of Ig-expressing cells upon exposure to self-
antigen. Because B cell development in E47/ mice was 
blocked at the Hardy fraction A/B cell stage, we were not 
able to assess how the complete absence of E47 affects the 
developmental progression of B cells beyond the pro–B cell 
stage. To address this issue and to compare the individual 
roles of E12 and E47 at the pre–B and immature B cell stage, 
we examined E12+/ and E47+/ mice for the abundance of 
upon exposure to self-antigen, the induction of receptor ed-
iting does not fully require E12 activity; however, E12 criti-
cally modulates the magnitude of the Ig response.
E47 and E12 abundance is limiting during the development 
of Ig-expressing B cells
The observations described in the previous section demon-
strate that E12 plays a critical role in the developmental 
Figure 2.  Essential role for E47 but not E12 in early B cell development. (A and B) Representative FACS analysis of bone marrow (A) and spleens 
(B) from wild-type, E47/, and E12/ mice. Numbers indicate percentages of B cells within the live cell fraction. Mean percentages of B cells 
(B220+CD19+) in the live cell gate as well as absolute B cell numbers in bone marrow (A) and spleens (B) are depicted. At least four independent experi-
ments using one to three mice per group were performed. Horizontal bars represent the mean. ***, P < 0.001. (C) Flow cytometry of bone marrow B cells 
from wild-type, E47/, and E12/ mice. Numbers indicate percentages of B cells within the live cell fraction (left) or the B220+CD43+ pro–B cell fraction 
(right). At least four independent experiments using one to three mice per group were performed. (D) Mean percentages of fraction A (HSABP-1), frac-
tion B (HSA+BP-1), and fraction C (HSA+BP-1+) cells within the pro–B cell (B220+CD43+) compartment of wild-type, E47/, and E12/ mice. At least 
four independent experiments using one to three mice per group were performed. ns, not significant.2276 DISTINCT FUNCTIONS FOR E12 AND E47 IN B CELL DEVELOPMENT | Beck et al.
of Ig1-3
+ B cells (Fig. 4, A and B). Similarly, the fraction of 
Ig-expressing cells in the spleen derived from E12+/ and 
E47+/ mice was significantly reduced as compared to wild-
type mice (Fig. 4 C).
Ig-expressing cells. Bone marrow cells derived from wild-
type, E12+/, E47+/, and E12/ mice were isolated and 
examined  for  the  expression  of  Ig.  Both  E12+/  and 
E47+/ mice showed a substantial reduction in the fraction 
Figure 3.  E12 is required to promote the development of B cells expressing Ig. Flow cytometric analysis of B cell populations in wild-type and 
E12/ mice. (A) Mean percentages of depicted cell types within the live cell gate and total numbers of pro–B cells (B220+IgMc-kit+), pre–B cells 
(B220+IgMCD25+), immature B cells (B220intermediateIgM+), and recirculating B cells (B220hiIgM+) in the bone marrow. Six independent experiments using 
one mouse per group were performed. (B) Mean percentages of depicted cell types within the live cell gate and total numbers of immature B cells 
(B220+IgM+IgDlo), transitional B cells (B220+IgM+IgD+), mature B cells (B220+IgMloIgD+), follicular B cells (B220+CD23+CD21+), and marginal zone B cells 
(B220+CD23CD21hi) in the spleen. Six independent experiments using one mouse per group were performed. (C) Representative FACS analysis of Ig-
expressing B cells in the bone marrow and spleen. Numbers indicate percentages of the depicted gates within the live cell fraction. Nine independent 
experiments using one mouse per group were performed. (D) Mean percentages and total numbers of newly formed Ig+ B cells (B220intermediateIg1-3
+) 
and recirculating Ig+ B cells (B220hiIg1-3
+) in the bone marrow as well as Ig+ B cells (B220+Ig1-3
+) in the spleen as gated in C. Nine independent ex-
periments using one mouse per group were performed. (E) Percentages of Ig+ cells within the B220+ fraction as well as the ratio of Ig+ to Ig+ B cells in 
the bone marrow (left) and spleen (right). Six independent experiments using one mouse per group were performed. All bar graphs show means ± SEM.  
**, P ≤ 0.01; ***, P < 0.001 (values are not significantly different from wild-type controls if there is no p-value depicted).JEM VOL. 206, September 28, 2009 
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Although the E12 and E47 exons were specifically ex-
cised in the null mutant mice, it remained possible that E12 
and E47 cross-regulate each other. To explore this possibil-
ity, we isolated mRNA from sorted pre–B cells derived from 
wild-type, E12+/, E47+/, or E12/ mice and determined 
the  mRNA  levels  of  E12  and  E47  by  quantitative  PCR   
(Fig. 4 D). Pre–B cells derived from E47+/ showed slightly 
elevated levels of E12 mRNA (Fig. 4 D, left). In contrast, 
E47 levels in E12+/ pre–B cells were not significantly al-
tered (Fig. 4 D, right). E12/ pre–B cells, on the other hand, 
showed a modest reduction in E47 levels (Fig. 4 D, right). 
These data indicate that E47 levels are modestly but signifi-
cantly reduced in E12/ pre–B cells. On the other hand, 
E47 abundance is not significantly affected in E12+/ pre–B 
cells. Furthermore, these data indicate that depletion of E47 
slightly but significantly elevates the expression of E12. Thus 
the defect in Ig-expressing cells in E47+/ and E12+/ mice 
cannot be explained by abnormalities in the abundance of ei-
ther E12 or E47. Collectively, these data demonstrate that 
both E12 and E47 play a critical role in the developmental 
progression of Ig-expressing B cells.
E12 and E47 facilitate Ig locus accessibility
Given that Ig-expressing cells were less abundant in E12+/, 
E47+/, and E12/ mice, we considered the possibility that 
E12 proteins act to regulate Ig VJ gene rearrangement. To 
address this issue, DNA was isolated from sorted pre–B cells 
derived from wild-type, E12+/, E47+/, and E12/ mice 
and analyzed by semiquantitative PCR for the presence of 
IgH DJ as well as Ig and Ig VJ gene rearrangements. IgH DJ 
and Ig VJ joining is not perturbed in pre–B cells isolated 
from E47+/, E12+/, and E12/ mice (Fig. S4). Recom-
bining sequence (RS) rearrangements were only modestly 
affected in E12+/, E47+/, and E12/ mice (Fig. 5 B, left 
and middle). In contrast, Ig V1-J1 rearrangement was sig-
nificantly reduced in pre–B cells isolated from both E12+/ 
and E47+/ mice (Fig. 5 B, right). As predicted, E12/ pre–
B cells showed a significant decrease in the levels of Ig VJ 
gene rearrangements as compared with wild-type mice and, 
importantly, also with E47+/ pre–B cells (Fig. 5 B, right). 
These data indicate that both E12 and E47 act to promote 
Ig VJ gene rearrangement.
To determine whether the decrease in Ig VJ gene rear-
rangements in E12+/ and E47+/ bone marrow cells was 
caused by lower levels of RAG1 and/or RAG2 expression, 
mRNA was isolated from sorted pre–B cells and examined 
by quantitative PCR for the expression of RAG1/2. Both 
RAG1 and RAG2 mRNA levels were not significantly 
altered in E12+/ and E47+/ as compared with wild-type 
mice (Fig. S5). To determine whether a reduction in E12 
and/or E47 affected Ig germline transcription, mRNA from 
sorted pre–B cells was analyzed for the expression of Ig1 
germline transcripts. Consistent with the decrease in Ig VJ 
gene rearrangements in E12+/ and E47+/ pre–B cells, Ig1 
germline transcript levels were significantly reduced as com-
pared with wild-type (Fig. 5 C). As expected, a further   
Figure 4.  E47 and E12 abundance is limiting during the develop-
ment of Ig-expressing B cells. (A–C) Mean percentages and total  
numbers of newly formed Ig+ B cells (B220intermediateIg1-3
+; A) and  
recirculating Ig+ B cells (B220hiIg1-3
+; B) in the bone marrow as well as 
Ig+ B cells (B220+Ig1-3
+; C) in the spleen as gated in Fig. 3 C from mice of 
the indicated genotypes. At least three independent experiments using one 
mouse per group were performed. (D) Quantitative PCR analysis of E12 and 
E47 transcripts in FACS-sorted pre–B cells (B220+IgMCD25+) from the 
bone marrow of wild-type, E12+/, E47+/, and E12/ mice. Levels were 
normalized to hypoxanthine guanine phosphoribosyl transferase 1 (Hprt1) 
transcripts and relative levels to wild-type controls are shown (2Ct). Bar 
graphs show means ± SEM of three independent experiments. *, P ≤ 0.05; 
**, P ≤ 0.01; ***, P < 0.001 (values are not significantly different from wild-
type controls if there is no p-value depicted). nd, not detectable.2278 DISTINCT FUNCTIONS FOR E12 AND E47 IN B CELL DEVELOPMENT | Beck et al.
regions (Rudin and Storb, 1992). To determine whether 
E12 and E47 directly interact with E-box sites present in the 
Ig  enhancer,  B  cells  were  isolated  from  wild-type  and 
E12/ bone marrow, cross-linked with formaldehyde, and 
immunoprecipitated with an anti-E2A antibody. Subse-
quently,  DNA  was  isolated  from  the  immunoprecipitates 
and examined for the presence of regions containing E1-3 
reduction in Ig germline transcription was observed in E12/ 
pre–B cells (Fig. 5 C). Collectively, these data suggest that E12 
and E47 activate Ig VJ gene rearrangement by modulating Ig 
locus accessibility to the recombination machinery.
Consistent with a role for E12 and E47 in modulating 
Ig locus accessibility are previous observations indicating the 
presence of E12 and E47 binding sites in the Ig enhancer 
Figure 5.  E12 and E47 facilitate Ig locus accessibility. (A) Schematic diagram of the mouse IgH and light chain (Ig and Ig) loci. V, D, J, and C 
segments as well as the RS in Ig are depicted as gray boxes and the enhancers are depicted as white boxes. Analyzed gene rearrangements are shown by 
arrows on top of the loci, whereas germline transcripts are shown by arrows under the gene locus. (B) Quantification of Southern blots from PCR analysis 
of Ig gene rearrangements in FACS-sorted pre–B cells (B220+IgMCD25+) from mice of the indicated genotypes. PCR products from reactions of fourfold 
serial dilutions were electrophoresed on agarose gels and abundance was quantitated by Southern blotting using specific probes. Shown are means ± 
SEM relative to wild-type signal. *, P ≤ 0.05; ***, P < 0.001 (values are not significantly different from wild-type controls if there is no p-value depicted). 
Three independent experiments using one mouse per group were performed. (C) Quantitative PCR analysis of Ig1 germline transcripts (Ig1°) in FACS-
sorted pre–B cells (B220+IgMCD25+) from the bone marrow of wild-type, E12+/, E47+/, and E12/ mice. Levels were normalized to Hprt1 transcripts 
and relative levels to wild-type controls are shown (2Ct). Shown are means ± SEM. *, P ≤ 0.05; **, P ≤ 0.01; ***, P < 0.001 (values are not significantly 
different from wild-type controls if there is no p-value depicted). Three independent experiments using one mouse per group were performed. (D) ChIP 
assays using anti-E2A antibodies on MACS-purified total B220+ bone marrow cells from wild-type and E12/ mice. Relative enrichment of the bound 
DNA over input was determined by quantitative PCR using specific primers for the Ig enhancers E1-3 and E2-4. Shown are means ± SEM. Two indepen-
dent experiments using one mouse per group were performed. IRS1, intronic recombination sequence 1.JEM VOL. 206, September 28, 2009 
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E47 expression increasing over time (Fig. 6 A). Concomitant 
with the increase in E12 and E47 mRNA levels, we observed 
an increase in Ig germline transcription consistent with a 
model in which E12 directly regulates Ig germline transcrip-
tion (Fig. 6 B). To determine whether E12 is required for the 
induction of Ig germline transcription, E12+/+, HEL-Tg and 
E12+/, HEL-Tg bone marrow cells were cultured in the 
presence of IL-7 for 4 d, followed by withdrawal of IL-7. 
RNA was isolated at the indicated time points and examined 
for  the  presence  of  Ig  germline  transcription.  Consistent 
with these observations, Ig germline transcript levels were 
significantly reduced in E12+/ immature B cells (Fig. 6 B).
E2A proteins modulate epigenetic marks  
across the Ig J regions
Intriguing studies have recently indicated a correlation be-
tween epigenetic marking and antigen receptor assembly. Spe-
cifically, a noncanonical plant homeodomain located within 
the noncore region of RAG2 was shown to interact with 
H3K4me3 (Liu et al., 2007; Matthews et al., 2007; Ramón-
Maiques et al., 2007). Furthermore, across the J region, 
H3K4me3 and H3 acetylation (H3ac) were shown to be spe-
cifically enriched during the pre–B and immature B cell stages 
(Xu and Feeney, 2009). These observations raise the possibil-
ity that the E2A proteins regulate Ig VJ gene rearrangement 
by promoting the recruitment of RAG2 to the recombination 
signal sequences by, directly or indirectly, modulating trimeth-
ylation of H3K4. To address this issue, B220+ bone marrow 
cells from wild-type and E12/ mice were cultured in the 
presence of IL-7 and stem cell factor for 8 d to obtain a homo-
geneous culture of B220+CD19+CD43+ pro–B cells. After   
IL-7 withdrawal for 18 h, we examined the J region for 
H3K4 trimethylation as well as H3ac by chromatin immuno-
precipitation (ChIP; Fig. 7, A and B). Interestingly, both 
and E2-4 using the appropriate primers. Both E12 and E47 
interacted with the Ig enhancer regions, E1-3 and E2-4, 
because the enrichment observed in wild-type bone marrow 
cells was severely reduced in E12/ cells but not abolished 
(Fig. 5 D). Thus, we conclude that the residual binding to 
the Ig enhancer regions is caused by E47 (Fig. 5 D). Col-
lectively, these data demonstrate that both E12 and E47 in-
teract with E-box sites present in the Ig enhancers, activate 
Ig germline transcription, modulate Ig locus accessibility, 
and promote Ig VJ gene rearrangement.
Attenuation of IL-7 signaling elevates E12  
and E47 abundance
Previous observations have indicated that E47 abundance is 
low in cycling large pre–B cells but is elevated in small resting 
pre–B cells (Quong et al., 2004). Because Ig light chain gene 
rearrangement is initiated by pre-BCR signaling as well as at-
tenuation of IL-7 signaling, we examined the temporal ex-
pression of E12 and E47 in bone marrow cells that express an 
innocuous BCR upon withdrawal of IL-7 signaling. In brief, 
B cells expressing the hen egg lysozyme transgene (HEL-Tg) 
were isolated from the bone marrow and grown for a period 
of 4 d in the presence of IL-7. Upon withdrawal of IL-7 from 
the B cell cultures, the abundance of Ig germline transcripts 
as well as E12 and E47 transcript levels were determined at 
various time points using quantitative PCR. Upon attenua-
tion of IL-7–mediated signaling, E12 and E47 transcript lev-
els increased gradually (Fig. 6 A). Interestingly, the relative 
increase  in  E12  expression  was  modestly  but  consistently 
larger than that of E47 expression, with the ratio of E12 to 
Figure 6.  Attenuation of IL-7 signaling elevates E12 and E47 
abundance. (A) Quantitative PCR analysis of E47 and E12 transcripts at 
various time points after IL-7 withdrawal from cell cultures of HEL-Tg B 
cells. Levels were normalized to Hprt1 transcripts, and expression levels 
relative to before IL-7 withdrawal are determined (2Ct). Shown are 
means ± SEM of three independent experiments. (B) Quantitative PCR 
analysis of Ig1 germline transcripts at various time points after IL-7 
withdrawal from B cell cultures generated from the bone marrow of 
HEL-Tg and E12+/, HEL-Tg mice. Levels were normalized to Hprt1 tran-
scripts and relative expression levels are determined (2Ct). Shown are 
means ± SEM of three independent experiments.
Figure 7.  E2A modulates the abundance of H3K4me3 across the 
Ig J regions. (A and B) ChIP assays using anti-H3K4me3 (A) or anti-
H3ac (B) antibodies on pro–B cell cultures from wild-type and E12/ 
mice that were deprived of IL-7 for 18 h. Relative enrichment of the 
bound DNA over input was determined by quantitative PCR using specific 
primers for the Ig J1 region. Shown are means ± SEM of two indepen-
dent experiments. *, P ≤ 0.05; **, P ≤ 0.01.2280 DISTINCT FUNCTIONS FOR E12 AND E47 IN B CELL DEVELOPMENT | Beck et al.
abundance of E12 caused by the insertion of the neomycin 
gene. Thus, an important unresolved question is whether 
E12 and E47 fulfill distinct and/or overlapping roles during B 
lymphopoiesis. In this study, we have generated two mouse 
strains that selectively delete either the E12 or the E47 exon 
through the usage of the loxP system, enabling us to study 
their specific roles during B cell development.
Previous studies have shown that B cell development in 
E2A-deficient mice is completely blocked at the prepro–B 
cell stage (Bain et al., 1994; Zhuang et al., 1994). Overex-
pression of either E12 or E47 has the ability of triggering 
commitment to the B cell lineage, raising the possibility that 
both play a role in B cell specification and/or commitment 
(Bain et al., 1997). Our study shows that E47 is strictly re-
quired for progression beyond the prepro–B cell stage and 
that endogenous levels of E12 cannot compensate for its loss. 
In striking contrast, E12-deficient mice show almost normal 
numbers of mature B cells in the bone marrow and spleen. 
However, the pre–B cell compartment is slightly reduced in 
E12-deficient bone marrow. We note that the decrease in 
the pre–B cell compartment of E12-deficient bone marrow 
might be caused by the twofold decrease in E47 mRNA lev-
els (Fig. 4 D). Thus, in the presence of endogenous levels of 
E47 protein, E12 is dispensable for the specification of the B 
cell fate. In turn, this suggests that E47 but not E12 activates 
a B lineage–specific program of gene expression.
In addition to regulating lineage decisions through the 
activation of gene expression of B cell–specific genes, the 
E2A proteins also play critical roles in regulating Ig gene   
H3K4me3 and H3ac across the J region were significantly 
reduced in the absence of E12 (Fig. 7, A and B).
Collectively, these data indicate that E12 expression is   
elevated in immature B cells to initiate Ig germline transcrip-
tion and to promote Ig locus accessibility. Based on these, as   
well as previous observations, we propose that in immature 
B cells initially, E12 and E47 abundance is low, preventing 
accessibility of the Ig locus to the recombination machin-
ery. However, increasing levels of E12 and E47 would even-
tually lead to relative high occupancy of E-box elements 
present in the Ig enhancer, inducing Ig germline transcrip-
tion and permitting the activation of Ig VJ gene rearrange-
ment (Fig. 8). Furthermore, we suggest that the E2A proteins 
act to promote epigenetic marking of histone residues lo-
cated at the J regions to permit the recruitment of RAG2 to 
the recombination machinery.
DISCUSSION
The Tcfe2a locus encodes for two highly related proteins that 
differ in their DNA binding region through alternative splic-
ing of one exon (Murre et al., 1989; Sun and Baltimore, 
1991). From previous studies, it is apparent that the transcrip-
tion factor E2A is not only indispensable for commitment to 
the B cell lineage but fulfills critical functions throughout B 
lymphopoiesis that include maintenance, DNA recombina-
tion, receptor editing, marginal versus follicular zone devel-
opment,  and  class  switch  recombination  (Greenbaum  and 
Zhuang, 2002b; Murre, 2005). We have previously gener-
ated E47-deficient mice that also showed substantially reduced 
Figure 8.  A gradient of E12 and E47 activity leads to the sequential activation of the Ig light chains. Attenuation of IL-7 signaling leads to an 
increase in E12 and E47 expression to initiate Ig light chain gene rearrangement. Signaling through a functional BCR suppresses E12/E47 expression to 
prevent further rearrangements and promote positive selection and maturation. However, in the absence of such a signal, the ratio of E12 to E47 reaches 
a certain threshold, which enables the cell to rearrange the Ig loci. Failure to generate a functional BCR during a certain time window will lead to cell 
death, presumably caused by high E12 and E47 levels.JEM VOL. 206, September 28, 2009 
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that Ig production in E12-ablated bone marrow cells is per-
turbed because of a reduction in RS deletion. However, in 
this study we show that RS deletion is only modestly affected 
in E12-deficient pre–B and immature B cells carrying unma-
nipulated BCRs. A third possibility is that E12 and E47 are 
required to activate the expression of RAG1/2. However, 
E12- and E47-heterozygous pre–B cells did not show de-
creased levels of either RAG1 or RAG2 mRNA. A fourth 
possibility, and one that we favor, is that E12 and E47 bind-
ing to the Ig enhancers directly allows the recombinase ac-
cess to the recombination signal sequences.
It is now well established that the Ig light chain loci re-
arrange sequentially. Specifically, Ig VJ rearrangements are 
initiated  before  the  onset  of  Ig  VJ  gene  rearrangement 
(Nadel et al., 1990; Engel et al., 1999). It has remained un-
clear how the sequential rearrangement of the Ig light chain 
genes is achieved during the developmental progression of 
B-lineage cells. We suggest that E12 and E47 are critical 
players that regulate the sequential activation of Ig versus 
Ig  loci.  Previous  observations  have  demonstrated  that 
E47 abundance in large cycling pre–B cells is low but ele-
vated during the transition toward the small pre–B cell stage 
(Quong et al., 2004). We also have previously proposed 
that at the pre–B cell stage, concurrent with the cessation of 
proliferation, E2A levels are elevated to initiate Ig VJ gene 
rearrangement (Quong et al., 2004). In this study, we show 
that attenuation of IL-7 signaling elevates both E12 and 
E47 expression. We speculate that once pre–B cells migrate 
away from IL-7–expressing stroma, E47 as well as E12 lev-
els increase to establish a gradient of E2A activity. This gra-
dient of E2A activity promotes the sequential activation of 
Ig versus Ig VJ gene rearrangement. In such a model, rel-
atively low levels of E47 would be sufficient to bind the 
E-box sites present in the Ig enhancer and to promote Ig 
locus  accessibility.  Initial  levels  of  E47  are  sufficient  to 
achieve high occupancy binding to E-box sites present in 
the Ig but not the Ig locus. The differences in the degree 
of occupancy by E12 and E47 in the Ig and Ig enhancers 
might be caused by interactions with other regulators. IRF-4 
is an attractive candidate because it has been shown to bind 
cooperatively with the E proteins to sites present in the Ig 
enhancers (Johnson et al., 2008). Thus, initially, E47 levels 
might be limiting and act in concert with IRF-4 to drive 
Ig VJ gene rearrangement but not to promote Ig accessi-
bility and DNA recombination. Later, during the pre–B to 
the immature B cell transition, the absence of an Ig or Ig 
chain or the expression of a self-reactive BCR would in-
crease E12 and E47 abundance to levels that allow sufficient 
occupancy at sites present in the Ig enhancers and, thus, 
drive Ig VJ recombination. On the other hand, because 
high levels of E47 reduce cell size and ultimately promote 
cell death, we suggest that the increase in E2A levels re-
stricts the time that is available for the B cells to generate a 
useful receptor (Fig. 8; Engel et al., 2001; Engel and Murre, 
2004). If, however, an innocuous BCR is generated, E12 
and E47 abundance declines, resulting in a decrease in Ig 
rearrangements. Both E47 as well as E12 were originally iden-
tified as factors that interact with the E2 site of the iE. Dele-
tion of the two E-boxes in iE affects Ig recombination to 
the same degree as deletion of the complete enhancer (Murre 
et al., 1989; Inlay et al., 2004). Forced E12 or E47 expression, 
in conjunction with RAG1 and RAG2, promotes Ig VJ 
gene rearrangement in nonlymphoid cells (Romanow et al., 
2000). Furthermore, Ig VJ gene rearrangements in E2A-
deficient pre–B cells are completely abolished (Lazorchak 
et al., 2006b; Kwon et al., 2008).
Collectively, these studies establish the E2A proteins as 
key regulators of Ig VJ gene rearrangement. We show in 
this study, however, that Ig VJ gene rearrangement is not 
affected in E12-deficient mice. Because B cell development 
in E47-deficient mice is completely blocked at the prepro–B 
cell stage and because we were not able to generate E47F/F 
mice that would permit the stage-specific deletion at the   
pre–B or immature B cell stage, we could not assess directly 
whether E47 is the critical component in promoting Ig VJ 
DNA  recombination.  However,  because  E2A-deficient  B 
cells are completely defective in Ig VJ recombination and 
E12 activity is not required, we infer that E47 is the main 
factor required to promote Ig VJ joining.
In contrast, we show in this study that both E47 and 
E12 are required for proper Ig gene rearrangement. As 
described, E12-deficient B cells show a reduction in E47 
mRNA levels that is similar to that observed in B cells from 
E47-heterozygous mice. Because E47-heterozygous B cells 
also have a significant defect in Ig VJ gene rearrangement, 
E12-deficient B cells cannot be used to evaluate the role of 
E12 in Ig VJ gene rearrangement. Therefore, E12-hetero-
zygous B cells that show normal levels of E47 were used to 
unambiguously demonstrate a critical role for E12 in Ig VJ 
gene rearrangement. We emphasize, however, that in addi-
tion to E12, E47 also plays a critical role in modulating Ig 
VJ gene rearrangement.
There are several mechanisms that may underpin the de-
crease in Ig-expressing cells in E12- or E47-deficient pre–B 
cells. First, it is conceivable that E12 and E47 act to promote 
the survival and/or life span of immature B cells, because 
previous studies have demonstrated a critical role for the E 
proteins in B cell survival (Kee et al., 2002; Lazorchak et al., 
2006b). In this case, however, survival of in vitro–cultured 
E12+/ B cells expressing the HEL-Tg is not affected, yet 
they do not efficiently up-regulate Ig germline transcripts. 
Thus, although we cannot exclude the possibility that the 
E2A proteins act, in part, to promote cell survival at the im-
mature B cell stage in vivo, we consider it unlikely that this 
is their sole function. A second possibility is that RS deletion 
is regulated by E12 and E47. RS is a DNA element that car-
ries a canonical recombination signal sequence. It is located 
25 kbp downstream of the Ig constant region and rear-
ranges by DNA recombination to V elements and to ele-
ments present in the J-C intronic region. The absence of 
RS deletion substantially interferes with the development of 
Ig-producing cells (Vela et al., 2008). Thus, it is conceivable 2282 DISTINCT FUNCTIONS FOR E12 AND E47 IN B CELL DEVELOPMENT | Beck et al.
lected with a flow cytometer (LSRII; BD) and were analyzed with FlowJo 
software (Tree Star, Inc.). Specific cell populations were either sorted on a 
FACSAria (BD) or isolated by magnetic cell sorting with anti-B220 or anti-
biotin microbeads (Miltenyi Biotec) according to the manufacturer’s proto-
col. The following antibodies were used for flow cytometry: anti-B220 
(RA3-6B2);  CD19  (1D3);  CD43  (R2/60);  BP-1  (6C3);  CD24/HSA 
(M1/69); CD117/c-kit (2B8); CD25 (PC61); IgM (II/41); IgD (11-26); 
CD21 (8D9); CD23 (B3B4); Ig light chain (187.1); Ig1, 2, and 3 light 
chain  (R26-46);  Flt3  (AF10.1);  CD127/IL-7R  (A7R34);  Sca1  (D7); 
Ter119 (TER-119); Gr1 (RB6-8C5); CD11b/Mac1 (M1/70); and CD3 
(145-2C11) and CD11c (N418). For CLP/LMPP sorting, the lineage cock-
tail contained antibodies against B220, Ter119, Gr1, CD11b/Mac1, CD3, 
and CD11c. Unspecific antibody binding was prevented by preincubation 
with CD16/CD32 Fc blocking solution (eBioscience).
Quantitative RT-PCR. Total RNA was isolated using the DNeasy kit 
(QIAGEN), and cDNA was prepared with oligo-dT primers using Super-
ScriptIII  reverse  transcription  (Invitrogen).  Quantitative  PCR  was  per-
formed using Brilliant SYBR Green Master Mix (Agilent Technologies) on 
the Mx3500P cycler (Agilent Technologies) using the gene-specific primers 
listed in Table S2 and a 60°C annealing temperature.
Bone marrow chimeras. Recipients were either -macroself transgenic 
mice or littermate controls that carried the CD45.1 allele and have been pre-
viously described (Ait-Azzouzene et al., 2005). Recipients received 1,000 
rads of  irradiation from a Cs source the day before transfer. Bone marrow 
donors were all of the CD45.2 allotype. Bone marrow cell suspensions were 
depleted of T cells by treatment with biotinylated anti-Thy1.2 antibodies and 
anti-biotin microbeads (Miltenyi Biotec). 10 million cells were transferred 
i.v. per recipient. After 6 wk, recipients were killed and their lymphoid tis-
sues were analyzed by flow cytometry. Only chimeras in which ≥98% of cells 
in the spleen were donor derived were included in the analysis.
PCR  assays  for  Ig  gene  recombinations. PCR reactions were per-
formed in a final volume of 25 µl containing 4, 1, and 0.25 ng of genomic 
DNA using the primers listed in Table S3. Specific probes were also gener-
ated by PCR using the primers listed in Table S4, gel purified using the 
QIAquick Gel Extraction Kit (QIAGEN), and radioactively labeled using 
the Prime-It Kit (Agilent Technologies). Samples were amplified for 25 cy-
cles of 94°C for 1 min, 60°C for 30 s, and 72°C for 1.5 min. PCR products 
were electrophoresed on 1.5% (0.8% for Ig V-J) agarose gels, blotted on 
nylon membranes (Schleicher & Schuell), and hybridized with radioactive 
probes. Signals were detected with a Phosphorimager (GE Healthcare) and 
analyzed using ImageJ software (available at http://rsbweb.nih.gov/ij/).
ChIPs. ChIP assays were performed as previously described (Agata et al., 
2007). In brief, B cells were fixed with 1% formaldehyde for 10 min at room 
temperature, lysed, and sonicated. Samples were precleared for 1 h with 
protein G beads, and ChIP was performed overnight using anti-E2A (anti-
E12  V18;  Santa  Cruz  Biotechnology,  Inc.),  anti-H3K4me3  (Millipore), 
anti–acetyl H3K9/14 (Millipore), or control normal rabbit IgG (Santa Cruz 
Biotechnology, Inc.). After washing and elution of the beads, cross-linking 
was reversed and protein was digested by proteinase K treatment. ChIP 
DNA was isolated using QIAquick PCR Purification Kit (QIAGEN) and 
analyzed by quantitative PCR using Brilliant SYBR Green Master Mix on 
an Mx3500P and the gene-specific primers listed in Table S5.
In vitro HEL-Tg B cell cultures. HEL-Tg mice, which bear rearranged 
IgH and Ig light chain genes that encode an HEL-specific BCR, were ob-
tained from the Jackson Laboratory. Whole bone marrow was isolated from 
4–6-wk-old HEL-Tg mice, and red blood cells were lysed and cultured in 
RPMI 1640 medium with 10% (vol/vol) FCS, 100 U/ml penicillin-strepto-
mycin, 2 mM l-glutamine, and 50 µM 2-mercaptoethanol in the presence 
of 1% conditioned supernatant of rIL-7–producing J558L cells for 4 d at 
37°C in 5% CO2. Remaining myeloid cells as well as surface IgD+ B cells 
and Ig occupancy and the promotion of positive selection 
(Quong et al., 2004).
An intriguing question is how the E2A proteins modulate 
the assembly of such a diverse set of antigen receptor loci, and 
the data described in this study may help to illuminate the 
mechanism by which the E2A proteins contribute to antigen 
receptor recombination. Recently, it was shown that RAG2 
associates with H3K4me3, establishing a direct link between 
epigenetic marking and antigen receptor assembly (Liu et al., 
2007; Matthews et al., 2007; Ramón-Maiques et al., 2007). 
In this study, we demonstrate that E12 elevates the abun-
dance of H3K4me3 across the Ig J regions in B cells poised 
to undergo Ig VJ gene rearrangement. Clearly, E12 is not 
the sole factor responsible for H3K4me3 because residual 
H3K4me3 remains across the J region in E12-deficient B 
cells, and consequently, other factors must contribute as well. 
There are several possible mechanisms of how E12 might 
modulate the degree of H3K4me3. First, it is possible that 
E12 contributes directly to the recruitment of methyltransfer-
ase activity acting on H3K4. Alternatively, E12 may function 
indirectly by activating Ig germline transcription, enabling 
methyltransferases and acetylases to travel with the RNA 
pol II complex, which then may lead to the trimethylation of 
H3K4. Collectively, these data have implications for the role 
of the E proteins in modulating the assembly of the large ma-
jority of antigen receptor loci (Murre, 2005). We suggest that 
the E proteins, directly or indirectly and in conjunction with 
other factors, act to promote epigenetic marking of antigen 
receptor loci across J regions to permit the recruitment of the 
RAG2 component of the recombinase.
In conclusion, this study demonstrates the multiple and 
unique functions displayed by the E2A isoforms E12 and 
E47. E47 is essential during B cell specification, commitment, 
and maintenance and it is necessary but not sufficient during 
the sequential rearrangement of the Ig and Ig loci. E12 and 
E47 are both required to promote Ig VJ rearrangement by 
modulating, at least in part, the trimethylation of H3K4 across 
the J region. Finally, we propose that in the pre–B and im-
mature B cell compartments, a gradient of E12 and E47 ac-
tivity is established to mechanistically regulate the sequential 
rearrangement of the Ig light chains.
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